Sonya Del Tredici and John Keenan

Addiction Medicine Journal Club

Sonya Del Tredici and John Keenan

  • 53. Methadone Vs. Buprenorphine

53. Methadone Vs. Buprenorphine

Monday 30th December 2024

Explore methadone vs buprenorphine for opioid use disorder with Dr. Keenan and Dr. Del Tredici. Discover key insights on treatment retention and patient care.
40 minutes
Informative
Engaging
Supportive
Educational
Compassionate

About this podcast

Addiction Medicine Journal Club
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
63 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Methadone vs Buprenorphine: A Deep Dive into Opioid Treatment Options

Episode Overview

  • Methadone promotes better retention in treatment compared to buprenorphine.
  • Mortality rates are low and similar for both medications.
  • Engaging non-abstinent patients is crucial for effective treatment.
  • The Modernizing Opioid Treatment Access Act aims to expand access to methadone.
  • Supporting frontline staff is essential in addiction care.
Retention and engagement should be the primary desired outcomes rather than drug abstinence.
In this episode of the Addiction Medicine Journal Club, Dr. John Keenan and Dr. Sonya Del Tredici dive into a comparison between methadone and buprenorphine for treating opioid use disorder. They discuss a recent study published in JAMA, which looks at treatment retention and mortality rates among patients using these medications. The conversation covers the nuances of each treatment option, including accessibility, patient preferences, and the broader implications for addiction medicine.
The hosts also touch on the Modernizing Opioid Treatment Access Act and the importance of engaging non-abstinent patients in treatment. They highlight the evolving views within the recovery community and the ongoing debate about medication-assisted treatment. The episode is packed with insights, practical advice, and real-world examples that can benefit both healthcare professionals and those affected by opioid use disorder. Don't miss out on this informative and engaging discussion that could change how you view addiction treatment.